Pathophysiological role of calpain in experimental demyelination

Journal of Neuroscience Research

Volumn 55, Issue 5, 1999, Pages 533-541

  Shields, Donald C ^a   Banik, Naren L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Calcium; Calpain; Calpastatin; Experimental allergic encephalomyelitis; Multiple sclerosis

Indexed keywords

CALCIUM; CALPAIN; CALPASTATIN; MYELIN PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; CELL ACTIVATION; CONTROLLED STUDY; DEMYELINATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITOR INTERACTION; ENZYME REGULATION; ENZYME SUBSTRATE COMPLEX; EXTRACELLULAR CALCIUM; INFLAMMATION; MULTIPLE SCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SHORT SURVEY;

ANIMALS; CALPAIN; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME ACTIVATION; HUMANS;

EID: 0033106023     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990301)55:5<533::AID-JNR1>3.0.CO;2-8     Document Type: Short Survey

References (76)

1. Azuma M, Inoue E, Oka T, Shearer TR. 1995. Proteolysis by calpain is an underlying mechanism for formation of sugar cataract in rat lens. Current Eye Res 14:27-34.
2. Banay-Schwartz M, Deguzman T, Palkovits M, Lajtha A. 1994. Calpain activity in adult and aged human brain regions. Neurochem Res 19:563-567.
3. Banik NL, Chakrabarti AK, Hogan EL. 1992. Role of calcium-activated neutral proteinase in myelin: its role and function. In: Martenson R, editor. Myelin. biology and chemistry. Caldwell, NJ: Telford Press. p 571-597.
4. Banik NL, Shields DC, Ray S, Davis B, Matzelle D, Wilford G, Hogan EL. 1998. Role of calpain in spinal cord injury: effects of calpain and free radical inhibitors. Ann NY Acad Sci 844:131-137.
5. Banno Y, Nakashima S, Hachiya T, Hozawa Y. 1995. Endogenous cleavage of phospholipase C beta 3 by agonist-induced activation of calpain in human platelets. J Biol Chem 270:4318-4324.
6. Barnes TM, Hodgkin J. 1996. The tra-3 sex determination gene of Caenorhabditis elegans encodes a member of the calpain regulatory protease family. EMBO J 15:4477-4484.
7. Bartus RT, Hayward NJ, Elliott PJ, Sawyer SD, Baker KL, Dean RL, Akiyama A, Straub JA, Herbeson SL, Li Z, Powers J. 1994. Calpain inhibitor AK295 protects neurons from focal brain ischemia. Stroke 25:2265-2270.
8. Bartus R, Heyward NJ, Elliott PJ, Sawyer SD, Dean RL, Akiyuama A, Straub JA, Harbeson SL, Li Z. 1995. Calpain inhibitor AK295 protects neurons from focal brain ischemia: effects of post-occlusion intra-arterial administration. Stroke 25:2265-2270.
9. Carillo S, Pariat M, Steff AM, Roux P, Etienne-Julian M, Lorca T, Piechaczyk M. 1994. Differential sensitivity of Fos and Jun family members to calpains. Oncogene 9:1679-1689.
10. Chakrabarti AK, Yoshida Y, Powers JM, Singh I, Hogan EL, Banik NL. 1988. Calcium-activated neutral proteinases in rat brain and subcellular fractions. J Neurosci Res 20:351-358.
11. Chakrabarti AK, Banik NL, Powers JM, Hogan EL. 1989. The regional and subcellular distribution of calcium-activated neutral proteinase (CANP) in the bovine central nervous system. Neurochem Res 14:259-266.
12. 2+-activated neutral proteinase (CANP): a role for glycoconjugates in CANP regulation. J Neurochem 54:1816-1819.
13. 2+ level. J Neurosci Res 44:374-380.
14. 2+ stores of T lymphocytes: changes induced by in vitro and in vivo activation. Euro J Immunol 24:1365-1371.
15. 2+-dependent proteinases (m-calpain and μ-calpain). J Biol Chem 264:10096-10103.
16. 2+ requirement for autolysis. J Biol Chem 259:11627-11630.
17. Crawford C. 1990. Protein and peptide inhibitors of calpains. In: Mellgren RL, Murachi T, editors. Intracellular calcium-dependent proteolysis. Boca Raton, FL: CRC Press. p 75-89.
18. Croall DE, DeMartino GN. 1990. Regulation of calcium-dependent protease activity in vitro: clues for determining their physiological functions. In: Mellgren RL, Murachi T, editors. Intracellular calcium-dependent proteolysis. Boca Raton, FL: CRC Press. p 103-114.
19. 2+ activated protease possibly involved in myofibrillar turnover. Biochemistry 15:2159-2167.
20. Denison SH, Orejas M, Arst HN. 1995. Signaling of ambient pH in Aspergillus involves a cysteine protease. J Biol Chem 270: 28519-28522.
21. Deshpande RV, Goust JM, Hogan EL, Banik NL. 1995. Calpain secreted by activated human lymphoid cells degrades myelin. J Neurosci Res 42:259-265.
22. Einstein ER, Csejtey J, Dalal KB, Adams CWM, Bayliss O, Hallpike J. 1972. Proteolytic activity and basic protein loss in and around multiple sclerosis plaques: combined biochemical and histochemical observations. J Neurochem 19:653-662.
23. Emori Y, Saigo K. 1994. Calpain localization changes in coordination with actin-related cytoskeletal changes during early embryonic development of Drosophila. J Biol Chem 269:25137-25142.
24. Guroff G. 1964. A neutral, calcium-activated proteinase from the soluble fraction of rat brain. J Biol Chem 239:149-155.
25. Imajoh S, Kawasaki H, Suzuki K. 1986. The amino-terminal hydrophobic region of the small subunit of calcium-activated neutral protease (CANP) is essential for its activation by phosphatidylinositol. J Biochem (Tokyo) 99:1281-1284.
26. Inuzuka T, Tamura A, Shuzo S, Korino T, Toyoshima I, Mlyatake Y. 1990. Suppressive effect of E-64 on ischemic degradation of cerebral proteins following occlusion of the middle cerebral artery in rats. Brain Res 526:177-179.
27. Kampfl A, Posmantur RM, Zhao X, Schmutzhard E, Clifton GL, Hayes RL. 1997. Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: a review and update. J Neurotrama 14:121-134.
28. Kawasaki H, Emori Y, Suzuki K. 1993. Calpastatin has two distinct sites for interaction with calpain - effect of calpastatin fragments on the binding of calpain to membranes. Arch Biochem Biophys 305:467-472.
29. Lee WJ, Ma H, Takano E, Yang HQ, Hatanaka M, Maki M. 1992. Molecular diversity in amino-terminal domains of human calpastatin by exon skipping. J Biol Chem 267:8437-8442.
30. Li J, Nixon R, Messer A, Berman S, Bursztajn S. 1998. Altered gene expression for calpain/calpastatin system in motor neuron degeneration (Mnd) mutant mouse brain and spinal cord. Molec Brain Res 53:174-186.
31. Linnington C, Lassmann H. 1987. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J Neuroimmunol 17:61-69.
32. Lynch G, Baudry M. 1984. The biochemistry of memory: a new and specific hypothesis. Science 224:1057-1063.
33. Maki M, Takano E, Osawa T, Ooi T, Murachi T, Hatanaka M. 1988. Analysis of structure-function relationship of pig calpastatin by expression of mutated cDNAs in Escherichia coli. J Biol Chem 263:10254-10261.
34. Maki M, Hatanaka M, Takano E, Murachi T. 1990. Structure-function relationship of calpastatins. In: Mellgren RL, Murachi T, editors. Intracellular calcium-dependent proteolysis. Boca Raton. FL: CRC Press. p 37-54.
35. Mellgren RL. 1987. Calcium-dependent proteases: an enzyme system active at cellular membranes. FASEB J 1:110-115.
36. Melloni E, Michetti M, Salamino F, Pontremoli S. 1998. Molecular and functional properties of a calpain activator protein specific for mu-isoforms. J Biol Chem 273:12827-12831.
37. 2+-activated neutral protease is active in the erythrocyte membrane in its nonautolyzed 80-kDa form. J Biol Chem 269:27992-27995.
38. Moller JR. 1996. Rapid conversion of myelin-associated glycoprotein to a soluble derivative in primates. Brain Res 741:27-31.
39. 2+-dependent protease (calpain) and its high-molecular-weight endogenous inhibitor (calpastatin). Adv Enzyme Regul 19:407-424.
40. 2+-requiring forms of calcium-activated neutral proteases. Biochemistry 28:449-455.
41. 2+-activated neutral proteinase specific for the intermediate filament proteins, vimentin and desmin. J Biol Chem 257:5544-5553.
42. Newcombe J, Glynn P, Cuzner ML. 1982. The immunological identification of brain proteins on cellulose nitrate in human demyelinating disease. J Neurochem 38:267-274.
43. Nixon RA. 1986. Fodrin degradation by calcium-activated neutral proteinase (CANP) in retinal ganglion cell neurons and optic glia: preferential localization of CANP activated in neurons. J Neurosci 6:1264-1271.
44. Nixon RA. 1989. Calcium-activated neutral proteinases as regulators of cellular function. Implications for Alzheimer's disease pathogenesis. Ann New York Acad Sci 568:198-208.
45. Ozawa K, Saida T, Saida K, Nishitani H, Kameyama M. 1989. In vivo CNS demyelination mediated by anti-galactocerebroside antibody. Acta Neuropathol (Berl) 77:621-628.
46. Patel Y, Kakkar VV, Authi KS. 1994. Calpain induced down-regulation of protein kinase C inhibits dense-granule secretion in human platelets. Inhibition of platelet aggregation or calpain activity preserves protein kinase C and restores full secretion. Biochim Biophys Acta 1224:480-488.
47. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Davaud C, Pasturaud P, Roudaut C, Hillaire D, Passos-Bueno MR, Zatz M, Tischrield JA, Fardeau M, Jackson CE, Cohen D, Beckmann JS. 1995. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81:27-40.
48. Saatman KE, Murai H, Bartus RT, Smith DH, Hayward NJ, Perri BR, McIntosh TK. 1996. Calpain inhibitor Ak295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc Nat Acad Sci USA 93:3428-3433.
49. Saido TC, Suzuki H, Yamazaki H, Tanoue K, Suzuki K. 1993. In situ capture of mu-calpain activation in platelets. J Biol Chem 268:7422-7426.
50. Saito Y, Saido TC, Sano K, Kawashima S. 1994. The calpain-calpastatin system is regulated differently during human neuroblastoma cell differentiation to Schwannian and neuronal cells. FEBS Lett 353:327-331.
51. Sakai K, Akanuma H, Imahori K, Kawashima S. 1987. A unique specificity of a calcium activated neutral protease indicated in histone hydrolysis. J Biochem 101:911-918.
52. Salamino F, De Tullio R, Michetti M, Mengotti P, Melloni E, Pontremoli S. 1994. Modulation of calpastatin specificity in rat tissues by reversible phosphorylation and dephosphorylation. Biochem Biophys Res Commun 199:1326-1332.
53. Sato S, Quarles RH, Brady RO, Tourtellotte WW. 1984. Elevated neutral proteinase activity in myelin from multiple sclerosis brain. Ann Neurol 15:264-267.
54. Schlaepfer WW. 1977. Vesicular disruption of myelin simulated by exposure of nerve to calcium ionophore. Nature 265:734-736.
55. Schlaepfer WW, Zimmerman UJP. 1990. The degradation of neurofilaments by calpains. In: Mellgren RL, Murachi T, editors. Intracellular calcium-dependent proteolysis. Boca Raton, FL: CRC Press. p 241-250.
56. Scolding NJ, Jones J, Compston DA, Morgan BP. 1990. Oligodendrocyte susceptibility to injury by T-cell perforin. Immunology 70:6-10.
57. Shearer TR, David LL. 1990. Calpains in lens and cataract. In: Mellgren RL, Murachi T, editors. Intracellular calcium-dependent proteolysis. Boca Raton, FL: CRC Press. p 265-276.
58. Shields DC, Banik NL. 1998a. Upregulation of calpain activity and expression in experimental allergic encephalomyelitis: a putative role for calpain in demyelination. Brain Res 794:68-74.
59. Shields DC, Banik NL. 1998b. Putative role of calpain in the pathophysiology of experimental optic neuritis. Exp Eye Res 67:403-410.
60. Shields DC, Tyor WR, Deibler GE, Banik NL. 1998a. Increased calpain expression in experimental demyelinating optic neuritis: an immunocytochemical study. Brain Res 784:299-304.
61. Shields DC, Tyor WR, Deibler GE, Hogan EL, Banik NL. 1998b. Increased calpain expression in activated glial and inflammatory cells in experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 95:5768-5772.
62. Silberberg DH, Manning MC, Schreiber AD. 1984. Tissue culture demyelinalion by normal human serum. Ann Neurol 15:575-580.
63. Smith ME 1979. Neutral protease activity in lymphocytes of Lewis rats with acute experimental allergic encephalomyelitis. Neurochem Res 4:689-702.
64. Smith M, Vandermaesen K, Somera F, Sobel R. 1998. Effects of phorbol myristate acetate (PMA) on functions of macrophages and microglia in vitro. Neurochem Res 23:427-434.
65. Sorimachi H, Ishiura S, Suzuki K. 1997. Structure and physiological function of calpains. Biochem J 328:721-732.
66. Springer JE, Azbill RD, Kennedy SE, George J, Geddes JW. 1997. Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment. J Neurochem 69:1592-1600.
67. Squirer MKT, Miller AKC, Malkinson AM, Cohen JJ. 1994. Calpain activation in apoptosis. J Cell Physiol 159:229-237.
68. 2+ ions. J Biochem 90:275-278.
69. Suzuki K, Imajoh S, Emori Y, Kawasaki H, Minami Y, Ohno S. 1987. Calcium-activated neutral protease and its endogenous inhibitor. FEBS Lett 220:271-277.
70. Takahashi K. 1990. Calpain substrate specificity. In: Mellgren RL, Murachi T, editors. Intracellular calcium-dependent proteolysis. Boca Raton, FL: CRC Press. p 55-74.
71. Takano E, Ueda M, Tsunekawa S, Murakami T, Maki M, Hatanaka M, Murachi T. 1991. Molecular diversity of erythrocyte calpastatin. Biomed Biochem Acta 50:517-521.
72. Tsubata T, Takahashi K. 1989. Limited proteolysis of bovine myelin basic protein by calcium-dependent proteinase from bovine spinal cord. J Biochem 105:23-28.
73. Yang HQ, Ma H, Takano E, Hatanaka M, Maki M. 1994. Analysis of calcium-dependent interaction between amino-terminal conserved region of calpastatin functinal domain and calmodulin-like domain of mu-calpain large subunit. J Biol Chem 269: 18977-18984.
74. Yano T, Kobayashi A, Kurata S, Natori S. 1997. Purification and characterization of cathepsin B mRNA 3'-untranslated-region-binding protein (CBBP), a protein that represses cathepsin B mRNA translation. Eur J Biochem 245:260-265.
75. Yao X, Thibodeau A, Forte JG. 1993. Ezrin-calpain I interactions in gastric parietal cells. Am J Physiol 265:C36-C46.
76. Zajicek JP, Wing M, Scolding NJ, Compston DA. 1992. Interactions between oligodendrocytes and microglia. A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing. Brain 115:1611-1631.